Tempus AI, Inc. Class A Common Stock
TEMTempus AI, Inc. Class A (TEM) is a technology company focused on developing artificial intelligence-driven solutions. It specializes in leveraging AI to improve efficiency and decision-making in various industries, including finance, healthcare, and enterprise services. The company aims to deliver innovative software and data analytics tools to enhance business operations and insights.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 28, 2006 | $0.44 | 2006-07-18 | 2006-07-20 |
| July 28, 2006 | $0.26 | 2006-07-18 | 2006-07-20 |
| June 22, 2005 | $0.23 | 2005-06-10 | 2005-06-14 |
| June 28, 2004 | $0.22 | 2004-06-21 | 2004-06-23 |
| June 26, 2003 | $0.20 | 2003-06-16 | 2003-06-18 |
Dividends Summary
- Consistent Payer: Tempus AI, Inc. Class A Common Stock has rewarded shareholders with 5 dividend payments over the past 3 years.
- Total Returned Value: Investors who held TEM shares during this period received a total of $1.35 per share in dividend income.
- Latest Payout: The most recent dividend of $0.44/share was paid 7295 days ago, on July 28, 2006.
- Dividend Growth: Since 2003, the dividend payout has grown by 117.9%, from $0.20 to $0.44.
- Growth Streak: TEM has raised its dividend for 5 consecutive payments.
Company News
Nano Dimension and Infinite Epigenetics announced a proposed business combination to create an AI-powered preventive health and diagnostics company. Nano Dimension's board selected Infinite Epigenetics after evaluating approximately 20 opportunities, citing its established epigenetics science, CLIA-certified laboratory, 120,000+ biological sample...
Ventripoint Diagnostics announced support for the newly formed Global Congenital Heart Disease Alliance (GCHDA), positioning its AI-powered VMS+ cardiac imaging platform to address a critical global healthcare gap. With 16 million people living with congenital heart disease and over 90% of children in lower-income countries lacking timely care, V...
Tempus AI is positioning itself as a healthcare AI winner with its growing data platform, AI tools, FDA progress, and pharma partnerships. However, the stock already reflects high expectations, making execution critical for investors seeking meaningful upside.
The Nasdaq 100 fell 0.7% as chip stocks stumbled, with Broadcom cratering 15% despite beating earnings due to weak AI-chip revenue guidance. The Dow Jones rallied 1.7% on defensive and financial strength, while the S&P 500 remained flat. Bitcoin hit a 4-month low at $61,310. Other tech stocks like CrowdStrike, Ciena, and Five Below also declined ...
Bristol-Myers Squibb announced a strategic partnership with Anthropic to deploy advanced AI capabilities across its operations, focusing on drug discovery and development in oncology and neuroscience. The collaboration will leverage AI, multimodal data, and Tempus' analytical platform to streamline research, clinical development, and manufacturin...
